Resmed Inc Dl 004 Aktie - RME

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Current Price

220,50

Gebot

219,30

Fragen

221,40

Volumen

0,00

0,00 Tagesbereich 0,00

169,00 52-Wochen-Bereich 250,00

Handelsende

220,50

Handelsbeginn

Letzte Trade

Letzter Handelszeitpunkt

Durchschnittliches Volumen (3 Mio.)

176

Finanzvolumen

VWAP

Resmed Champions Sleep Health as The Official Sleep Partner of The Qatar Airways British & Irish Lions Tour to Australia 2025

Resmed Champions Sleep Health as The Official Sleep Partner of The Qatar Airways British & Irish Lions Tour to Australia 2025 SAN DIEGO and...

Resmed Acquires VirtuOx

Resmed Acquires VirtuOx Acquisition supports Resmed’s growth in virtual care, expands access to diagnosis, and enhances the digital experience for...

Resmed Names Salli Schwartz as Chief Investor Relations Officer

Resmed Names Salli Schwartz as Chief Investor Relations Officer Former Illumina, MSCI, and Moody’s executive brings extensive experience leading...

New Global Study Finds: Sleep Apnea Patients Who Use CPAP Live Longer

New Global Study Finds: Sleep Apnea Patients Who Use CPAP Live Longer Largest ever meta-analysis on the long-term benefits of CPAP therapy...

Resmed Unveils Unified Brand to Lead the Global Sleep and Health Technology Revolution

Resmed Unveils Unified Brand to Lead the Global Sleep and Health Technology Revolution Brand Evolution Unites Brands Under One Resmed Identity to...

ResMed’s Fifth Annual Global Sleep Survey Reveals a World Struggling with Poor Sleep

ResMed’s Fifth Annual Global Sleep Survey Reveals a World Struggling with Poor Sleep New insights from 30,026 people across 13 markets show the...

Vaping Expected to Increase COPD Health and Economic Burden by 2050

Vaping Expected to Increase COPD Health and Economic Burden by 2050 New ResMed-supported research presented at ERS 2024 projects future Chronic...

PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia

PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia ResMed studies...

ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis

ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis 36,000 people across 17 markets responded to the company’s fourth...

ResMed Adopts New Operating Model to Accelerate Long-term Growth

ResMed Adopts New Operating Model to Accelerate Long-term Growth Justin Leong appointed Chief Product Officer, effective immediately.Katrin...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	3.9	1.80055401662	216.6	221.5	216	82	220.14233577	DE
4	4.7	2.17794253939	215.8	222.3	211	193	217.36349288	DE
12	15.5	7.56097560976	205	224	182.05	176	211.34769053	DE
26	-2.5	-1.12107623318	223	250	182.05	196	217.92044031	DE
52	49.95	29.2875989446	170.55	250	169	268	213.49104567	DE
156	68.5	45.0657894737	152	250	126.25	381	179.82608783	DE
260	68.5	45.0657894737	152	250	126.25	381	179.82608783	DE

RME - Frequently Asked Questions (FAQ)

What is the current Resmed Inc Dl 004 share price?

The current share price of Resmed Inc Dl 004 is 220,50 €

What is the 1 year trading range for Resmed Inc Dl 004 share price?

Resmed Inc Dl 004 has traded in the range of 169,00 € to 250,00 € during the past year

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
013CJDcom Inc	14,128 € (0,00%)	0
013AJD.com Inc	28,05 € (0,00%)	0
0110Thesis Gold Inc	0,652 € (0,00%)	0
00WAspermont Ltd	0,0035 € (0,00%)	0
000Greenvolt Energias Renovaveis SA	0,00 € (0,00%)	0
013CJDcom Inc	14,128 € (0,00%)	0
013AJD.com Inc	28,05 € (0,00%)	0
0110Thesis Gold Inc	0,652 € (0,00%)	0
00WAspermont Ltd	0,0035 € (0,00%)	0
000Greenvolt Energias Renovaveis SA	0,00 € (0,00%)	0
013CJDcom Inc	14,128 € (0,00%)	0
013AJD.com Inc	28,05 € (0,00%)	0
0110Thesis Gold Inc	0,652 € (0,00%)	0
00WAspermont Ltd	0,0035 € (0,00%)	0
000Greenvolt Energias Renovaveis SA	0,00 € (0,00%)	0

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Resmed Inc Dl 004 (RME)

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

RME Neueste Nachrichten

Resmed Champions Sleep Health as The Official Sleep Partner of The Qatar Airways British & Irish Lions Tour to Australia 2025

Resmed Acquires VirtuOx

Resmed Names Salli Schwartz as Chief Investor Relations Officer

New Global Study Finds: Sleep Apnea Patients Who Use CPAP Live Longer

Resmed Unveils Unified Brand to Lead the Global Sleep and Health Technology Revolution

ResMed’s Fifth Annual Global Sleep Survey Reveals a World Struggling with Poor Sleep

Vaping Expected to Increase COPD Health and Economic Burden by 2050

PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia

ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis

ResMed Adopts New Operating Model to Accelerate Long-term Growth

RME - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Resmed Inc Dl 004 (RME) Börsenkurse

Resmed Inc Dl 004 (RME)

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

RME Neueste Nachrichten

Resmed Champions Sleep Health as The Official Sleep Partner of The Qatar Airways British & Irish Lions Tour to Australia 2025

Resmed Acquires VirtuOx

Resmed Names Salli Schwartz as Chief Investor Relations Officer

New Global Study Finds: Sleep Apnea Patients Who Use CPAP Live Longer

Resmed Unveils Unified Brand to Lead the Global Sleep and Health Technology Revolution

ResMed’s Fifth Annual Global Sleep Survey Reveals a World Struggling with Poor Sleep

Vaping Expected to Increase COPD Health and Economic Burden by 2050

PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia

ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis

ResMed Adopts New Operating Model to Accelerate Long-term Growth

RME - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Anmelden

Werbung entfernen